HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chi-Tang Ho Selected Research

nobiletin

4/2021Bidirectional interaction of nobiletin and gut microbiota in mice fed with a high-fat diet.
4/2021The biological fate and bioefficacy of citrus flavonoids: bioavailability, biotransformation, and delivery systems.
6/2019Nobiletin Prevents Trimethylamine Oxide-Induced Vascular Inflammation via Inhibition of the NF-κB/MAPK Pathways.
8/2018Nobiletin and 5-Hydroxy-6,7,8,3',4'-pentamethoxyflavone Ameliorate 12- O-Tetradecanoylphorbol-13-acetate-Induced Psoriasis-Like Mouse Skin Lesions by Regulating the Expression of Ki-67 and Proliferating Cell Nuclear Antigen and the Differentiation of CD4+ T Cells through Mitogen-Activated Protein Kinase Signaling Pathways.
3/2015Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene.
2/2010Nobiletin metabolite, 3',4'-dihydroxy-5,6,7,8-tetramethoxyflavone, inhibits LDL oxidation and down-regulates scavenger receptor expression and activity in THP-1 cells.
3/2009Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel inhibit growth of human lung cancer cells by apoptosis.
11/2006Comparison of supercritical fluid chromatography and liquid chromatography for the separation of urinary metabolites of nobiletin with chiral and non-chiral stationary phases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chi-Tang Ho Research Topics

Disease

127Neoplasms (Cancer)
01/2022 - 01/2002
63Inflammation (Inflammations)
04/2022 - 06/2002
45Obesity
06/2022 - 02/2012
40Carcinogenesis
09/2021 - 06/2002
31Breast Neoplasms (Breast Cancer)
06/2020 - 12/2006
20Neoplasm Metastasis (Metastasis)
12/2021 - 07/2009
18Colonic Neoplasms (Colon Cancer)
01/2022 - 04/2003
16Body Weight (Weight, Body)
01/2022 - 01/2010
12Insulin Resistance
06/2022 - 01/2014
12Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2009
12Hepatocellular Carcinoma (Hepatoma)
01/2018 - 07/2009
11Leukemia
07/2022 - 06/2006
11Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2002
10Non-alcoholic Fatty Liver Disease
04/2022 - 01/2014
10Liver Cirrhosis (Hepatic Cirrhosis)
11/2021 - 02/2013
9Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2014
8Dehydration (Water Stress)
07/2022 - 03/2018
8Triple Negative Breast Neoplasms
12/2021 - 07/2013
8Prostatic Neoplasms (Prostate Cancer)
12/2016 - 02/2002
7Fibrosis (Cirrhosis)
11/2021 - 06/2013
7Colitis
06/2021 - 04/2012
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2019 - 11/2013
7Papilloma (Papillomatosis)
02/2014 - 11/2006
6Diabetes Mellitus
03/2022 - 12/2006
6Lung Neoplasms (Lung Cancer)
07/2019 - 03/2009
6Liver Neoplasms (Liver Cancer)
01/2016 - 12/2010
6Edema (Dropsy)
07/2011 - 01/2002
5Necrosis
11/2019 - 06/2015
5Aberrant Crypt Foci
09/2014 - 09/2005
4Chronobiology Disorders (Circadian Rhythm Disorder)
05/2022 - 08/2019
4Type 2 Diabetes Mellitus (MODY)
04/2022 - 03/2016
4Atherosclerosis
01/2022 - 01/2007
4Colitis-Associated Neoplasms
01/2021 - 09/2014
4Weight Loss (Weight Reduction)
09/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2004
30pterostilbeneIBA
04/2022 - 09/2007
30TeaIBA
03/2022 - 01/2002
23Biological ProductsIBA
07/2021 - 01/2004
22ResveratrolIBA
01/2022 - 04/2003
21AntioxidantsIBA
06/2021 - 01/2009
17FlavonoidsIBA
05/2022 - 12/2007
17LipidsIBA
04/2022 - 12/2006
16CurcuminIBA
11/2021 - 05/2008
15PhytochemicalsIBA
07/2022 - 01/2006
13PolyphenolsIBA
01/2022 - 01/2002
12Messenger RNA (mRNA)IBA
01/2022 - 01/2010
12garcinolIBA
01/2021 - 04/2005
11anthraceneIBA
01/2021 - 01/2006
10EnzymesIBA
09/2021 - 11/2008
10StilbenesIBA
06/2021 - 03/2008
10AzoxymethaneIBA
01/2021 - 08/2010
10Reactive Oxygen Species (Oxygen Radicals)IBA
07/2019 - 11/2005
10CaspasesIBA
01/2016 - 11/2005
9Insulin (Novolin)FDA Link
04/2022 - 01/2014
9Therapeutic UsesIBA
01/2022 - 03/2008
9Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2014
95- hydroxy- 3,6,7,8,3',4'- hexamethoxyflavoneIBA
03/2015 - 12/2006
8Glucose (Dextrose)FDA LinkGeneric
10/2021 - 09/2014
8CytokinesIBA
06/2021 - 02/2006
8nobiletinIBA
04/2021 - 11/2006
8CholesterolIBA
12/2020 - 08/2014
7Dronabinol (THC)FDA LinkGeneric
12/2021 - 11/2011
7gingerolIBA
03/2018 - 05/2008
7shogaolIBA
03/2015 - 05/2008
6Antineoplastic Agents (Antineoplastics)IBA
11/2021 - 12/2007
6Dextran SulfateIBA
09/2021 - 04/2012
6Biomarkers (Surrogate Marker)IBA
02/2020 - 02/2006
53'-hydroxypterostilbeneIBA
04/2022 - 01/2014
5Blood Glucose (Blood Sugar)IBA
04/2022 - 09/2018
5Hypoglycemic Agents (Hypoglycemics)IBA
03/2022 - 12/2014
5Capsaicin (Zostrix)FDA Link
01/2022 - 05/2017
5Carnitine (L-Carnitine)FDA LinkGeneric
01/2022 - 06/2014
5allicinIBA
01/2022 - 08/2012
5trimethyloxamine (trimethylamine N-oxide)IBA
01/2022 - 01/2019
5Carbon Tetrachloride (Tetrachloromethane)IBA
11/2021 - 09/2017
5DiarylheptanoidsIBA
11/2021 - 08/2012
5sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2021 - 01/2017
5Dextrans (Dextran)FDA Link
01/2021 - 01/2017
5Interleukin-6 (Interleukin 6)IBA
03/2020 - 02/2006
5tetrahydrocurcuminIBA
01/2020 - 11/2011
5CateninsIBA
12/2019 - 02/2011
5Transcription Factors (Transcription Factor)IBA
01/2018 - 02/2011
5Pharmaceutical PreparationsIBA
09/2016 - 11/2013
5theaflavinIBA
06/2015 - 01/2002
5Arachidonic Acid (Vitamin F)IBA
01/2011 - 04/2003
43,3',4,5'-tetrahydroxystilbeneIBA
01/2022 - 10/2016
4Xylose (D-Xylose)FDA Link
12/2021 - 09/2018
45-demethylnobiletinIBA
09/2021 - 05/2011
4AcidsIBA
07/2021 - 04/2011
4Amyloid (Amyloid Fibrils)IBA
03/2021 - 10/2016
4Peptides (Polypeptides)IBA
03/2021 - 10/2016
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 09/2014
4LipopolysaccharidesIBA
03/2020 - 05/2010
4Glutathione (Reduced Glutathione)IBA
08/2019 - 08/2006
4tangeretinIBA
08/2018 - 10/2002
4oxidized low density lipoproteinIBA
04/2018 - 01/2007

Therapy/Procedure

23Therapeutics
01/2022 - 02/2002
19Chemoprevention
11/2020 - 01/2002
8Drug Therapy (Chemotherapy)
07/2022 - 03/2008
8Oral Administration
04/2020 - 02/2006